PRODUCT TYPES – Page 13

Cross-contamination risk during inspection prep: containment CAPA and effectiveness checks

Identifying signals of potential cross-contamination is crucial for timely intervention. Symptoms may manifest in several forms, often recognized during routine checks or specific inspection preparations:Click to read the full article.

Finished product particulate matter OOS during EMA/MHRA inspection preparation: how to defend specification setting and outlier handling during inspection

Identifying symptoms related to particulate matter deviations is the first step in understanding the issue at hand. Common signals in the laboratory or manufacturing environment may include:Click to read the…

Stability failure after equipment cleaning: containment CAPA and effectiveness checks

Identifying symptoms or signals is the first step in addressing stability failures. In a manufacturing environment, various indicators may suggest that a stability issue has arisen following equipment cleaning:Click to…

Finished product fill weight / volume variability during routine batch release: how to build a deviation package that passes an inspection deep-dive

Variability in fill weight and volume can manifest through several signals during production and testing phases:Click to read the full article.

Cross-contamination risk during stability pull: containment CAPA and effectiveness checks

Identifying signals indicating potential cross-contamination is crucial for timely intervention. Symptoms can manifest in various ways, including unexpected stability test results, complaints regarding product quality from either internal teams or…

Finished product fill weight / volume variability during routine batch release: stability strategy adjustments and packaging risk mitigation steps

Understanding the initial signals that indicate fill weight or volume variability is crucial. Symptoms may manifest at different stages of the production process, and their timely identification can prevent escalated…

Cross-contamination risk after equipment cleaning: containment CAPA and effectiveness checks

Identifying symptoms or signals of potential cross-contamination is the first step in the investigation process. Symptoms may vary across different production processes. Common indicators include:Click to read the full article.

Finished product transport excursion stability impact during PAI / FDA inspection readiness: how to build a deviation package that passes an inspection deep-dive

Identifying symptoms of a potential transport excursion is the first step in ensuring product integrity. Symptoms may manifest in various forms, ranging from deviations recorded in environmental monitoring reports to…

Assay drift during stability pull: risk assessment for patient safety

The first step in addressing assay drift during stability pulls is to identify the specific symptoms or signals. These indicators can manifest in various ways:Click to read the full article.

Finished product out-of-spec pH during complaint trending review: how to build a deviation package that passes an inspection deep-dive

Recognizing the symptoms that accompany OOS pH results is crucial for timely intervention. Common signals include:Click to read the full article.

Potency OOS after equipment cleaning: risk assessment for patient safety

Symptoms or signals on the manufacturing floor and laboratory provide critical indicators of possible potency OOS events. Below are key signs to monitor:Click to read the full article.

Finished product hardness / friability drift during EMA/MHRA inspection preparation: CAPA plan that inspectors accept (with effectiveness checks and due dates)

Detecting variations in product hardness and friability is crucial during the production process. Some key signals that may indicate a potential issue include:Click to read the full article.